Updated:
EPIRUS Biopharmaceuticals, Inc.
EPIRUS Biopharmaceuticals, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001135906, and its reported...
Overview
EPIRUS Biopharmaceuticals, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001135906, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2016-03-29, it reported net income of USD -52,188,000; total assets of USD 72,264,000 for the fiscal period ended 2015-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- EPIRUS Biopharmaceuticals, Inc.
- Former names in filing history
- Zalicus Inc. (2010-09-09 to 2014-07-02); COMBINATORX, INC (2004-12-10 to 2010-08-10); COMBINATORX INC (2002-09-12 to 2004-02-26)
- Classification
- Company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- Boston, MA, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 0001135906
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Revenue | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|---|
| FY2015USD | — | -$52.2M | $72.3M | $31.5M | — | |
| FY2014USD | — | -$41.8M | $51.4M | $21.5M | — | |
| FY2013USD | $14.7M | -$38.6M | $32.1M | $18.0M | -$29.7M | |
| FY2012USD | $12.6M | -$44.3M | $61.4M | $4.5M | -$38.5M |
FY2014. Total assets: shown as originally filed; later filings report different values for the same periods.
FY2013. Net income, Total assets, Cash and equivalents: shown as originally filed; later filings report different values for the same periods.
FY2012. Cash and equivalents: shown as originally filed; later filings report different values for the same periods.
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | 8-K | ||
| 10-K/A | 10-K/A | ||
| 10-K | 10-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research EPIRUS Biopharmaceuticals, Inc. in Altss
Track this company’s investors, transactions and relationships in Altss.